Compounds > azoxymethane
Page last updated: 2024-08-23

azoxymethane and Alloxan Diabetes

azoxymethane has been researched along with Alloxan Diabetes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, S; Hata, K; Hirose, Y; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H1
Hata, K; Hirose, Y; Iwasa, J; Moriwaki, H; Shimizu, M; Shirakami, Y; Shiraki, M; Tanaka, T; Tsurumi, H; Yasuda, Y1
Hara, A; Hata, K; Hirose, Y; Kubota, M; Kuno, T; Moriwaki, H; Shimizu, M; Tanaka, T1
Fujii, G; Komiya, M; Mutoh, M; Nakano, K; Takahashi, M; Takasu, S; Teraoka, N; Ueno, T; Wakabayashi, K; Yamamoto, M; Yanaka, A1
Hata, K; Hirose, Y; Kuno, T; Mori, H; Reddy, BS; Sakata, K; Tanaka, T; Yamada, Y; Yoshida, K1

Other Studies

5 other study(ies) available for azoxymethane and Alloxan Diabetes

ArticleYear
(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Catechin; Cholesterol; Colonic Neoplasms; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Insulin; Intestinal Mucosa; Leptin; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Receptor, IGF Type 1; Triglycerides

2008
Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-01, Volume: 15, Issue:9

    Topics: Amino Acids, Branched-Chain; Animals; Azoxymethane; beta Catenin; Body Weight; Carcinogens; Colonic Neoplasms; Diabetes Mellitus, Experimental; Dietary Supplements; Insulin; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Obesity; Organ Size; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Receptor, IGF Type 1; Receptor, IGF Type 2; Tumor Cells, Cultured

2009
Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis.
    Carcinogenesis, 2012, Volume: 33, Issue:3

    Topics: Animals; Azoxymethane; Colonic Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Susceptibility; Hypercholesterolemia; Hyperglycemia; Hyperinsulinism; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred ICR; Precancerous Conditions; Receptor, IGF Type 1; RNA, Messenger; Sodium Glutamate

2012
Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8

    Topics: Aberrant Crypt Foci; Adipokines; Animals; Azoxymethane; Biomarkers; Carcinogens; Colorectal Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hypoglycemic Agents; Immunoenzyme Techniques; Insulin; Intra-Abdominal Fat; Leptin; Lipids; Mice; Mice, Inbred C57BL; Obesity; Pioglitazone; PPAR gamma; Thiazolidinediones

2012
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Carcinogenesis, 2004, Volume: 25, Issue:5

    Topics: Animals; Azoxymethane; Blood Glucose; Body Weight; Carcinogens; Colonic Neoplasms; Diabetes Mellitus, Experimental; Heterozygote; Homozygote; Hyperinsulinism; Immunoblotting; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Precancerous Conditions; Receptor, IGF Type 1; Receptors, Cell Surface; Receptors, Leptin

2004